Shareholding22 Jul 2026, 05:21 pm
Clarus Capital I Acquires 5.13% Stake in Bliss GVS Pharma
AI Summary
Bliss GVS Pharma Ltd has announced that Clarus Capital I, along with its associated schemes (Clarus Capital I - LVF 1 and Clarus Capital 1 - LVF 2), collectively referred to as the 'Acquirer', has acquired a 5.13% stake in the company. This acquisition, managed by ChrysCapital Associates LLP, involved the purchase of 1,84,652 equity shares through open market transactions. The total holding of the Acquirer and its persons acting in concert (PAC), including ClearEdge LLC, now stands at 54,38,523 shares, crossing the 5% threshold as per SEBI's Takeover Regulations. The acquisition was completed on July 20, 2026, with the shares having a face value of Rs. 1/- each.
Key Highlights
- Clarus Capital I group acquired 1,84,652 shares via open market.
- Total holding of acquirer and PACs now stands at 5.13%.
- Acquisition triggers disclosure under SEBI Takeover Regulations.
- ChrysCapital Associates LLP is the investment manager.
- Acquisition date is July 20, 2026.
Price Impact
More from BLISSGVS